Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
1454GCC: Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments
- Status
- COMPLETED
- Phase
- PHASE3
Is Glucagon-like Peptide-1 Insufficiency a Residual Risk in Coronary Artery Disease?
- Status
- COMPLETED
- Phase
- N/A
Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
- Status
- COMPLETED
- Phase
- PHASE3
Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis
- Status
- COMPLETED
- Phase
- PHASE3
A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)
- Status
- COMPLETED
- Phase
- PHASE1
Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Pharmacokinetics of MK-7680 in Participants With Hepatitis C (MK-7680-003)
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers
- Status
- TERMINATED
- Phase
- PHASE1
Establishing Visualization Grading Scale on LESS Cholecystectomy
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma
- Status
- TERMINATED
- Phase
- PHASE3
Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902)
- Status
- COMPLETED
- Phase
- PHASE4
A Phase 2 Study of Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045)
- Status
- COMPLETED
- Phase
- PHASE3
Sitagliptin and Glucagon Counterregulation
- Status
- COMPLETED
- Phase
- PHASE4
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
- Status
- COMPLETED
- Phase
- PHASE2